Objectives-To examine the relation between rheumatoid arthritis (RA)
An association between rheumatoid arthritis (RA) and bronchiectasis (BR) is well recognised, '3 and similarities exist between these disorders. Both are associated with autoantibodies and abnormal serum immunoglobulin levels, and these may reflect disease severity in BR4 and RA.5 6 This paper reports a study of whether such abnormalities might be additive in the presence of the two diseases, whether this is reflected in more severe RA or BR, and discusses explanations for the association of these disorders in the light of the findings. Patients but whether these were initially prescribed for respiratory disease or RA was uncertain. No significant differences existed in the frequency of autoantibodies in the RA-BR and RA groups, though as might be expected autoantibodies were found less commonly in the group with BR alone (table 3) .
Increased serum IgA levels were found in a substantial proportion of subjects from all groups and reduced IgM levels were found more commonly in the two bronchiectasis groups than in the group with RA alone (Fisher's exact probability: RA-BR, p=0O052; BR, p=0006). Mean immunoglobulin levels (table 4) , however, were similar in all three groups. Levels of complement C3, C4, C 1-INH and CH50 did not differ between the groups, but lower levels of circulating immune complexes and acute phase reactants were found in patients with BR than in those with RA-BR. This was statistically significant for haptoglobin (t=2-88; p=0 005) and (x, antitrypsin (t=2-48; p=0 016), but mean values remained within the normal ranges in all groups. High(%) 6 (8) 19 (14) 10 ( The proportion of patients with increased serum IgA, for example, was similar in all three patient groups, and of extra-articular features only xerophthalmia, as assessed by Schirmer's tear test, was more pronounced in the group with RA and BR.
The spirometric findings suggest that bronchiectatic lung in rheumatoid disease may differ slightly from bronchiectatic lung without rheumatoid disease, with more pronounced obstructive airways disease and less reversibility with bronchodilators. This conclusion, is, admittedly, open to criticism, given the history of lobectomy in several of the patients, which would alter their spirometry and make comparison with predicted values unreliable. The number of patients who had had an operation was, however, similar in the two groups, as was the duration of BR, so the findings may represent a true qualitative difference in bronchiectatic lung with and without rheumatoid disease. This difference could, however, merely reflect the effect of Sjogren's syndrome. This is said to be a factor in the development of obstructive airways disease in RA'0 and may explain why the more severe obstructive defects were found in patients with RA-BR, the group with most xerophthalmia.
Several explanations have been proposed to account for the association between RA and BR. Bamji and Cooke suggest that RA or its treatment might lead to an increased incidence of respiratory tract infections2 and so predispose to BR. This explanation is difficult to accept in our study group as BR tended to precede RA. Bronchiectasis itself therefore might be a more likely source of the association. In established BR, for example, the antigenic stimuli of chronic suppuration could have a role in causing RA.' This is supported by the finding that RA starts at a younger age in patients with BR. " As BR is not associated with more severe rheumatoid disease, however, it is unlikely that chronic suppuration per se simply drives the rheumatoid disease. If lung infection is in some way causally related to the onset of RA it is probably by allowing exposure to a range of bacterial antigenic stimuli, some of which may trigger the disease in a genetically susceptible subject.
Another possibility is that the two diseases may share a common vulnerability. 15 This could be explained by methodological differences such as BR not being specifically sought in these studies, or population differences in that disease duration tended to be shorter than in our study. More exciting, perhaps, is the fact that these studies have been in primary Sjogren's syndrome. Could it be the interplay between the disease processes of Sjogren's syndrome and rheumatoid disease that is important in the development of BR?
The association between RA and BR is now well recognised, and further investigation of this relation may reveal useful clues to the aetiopathogenesis of these disorders. In the short term, however, the patients affected can be reassured that BR will not adversely affect their RA.
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